论文信息 - Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems

Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems

Although biologic treatments have excellent efficacy for many autoimmune diseases, safety concerns persist. Understanding the absolute and comparative risks of adverse events in patient and disease subpopulations is critical for optimal prescribing of biologics.

[1] M Alan Brookhart,et al. Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. , 2005, American journal of epidemiology.

[2] Laura A. Levit,et al. Beyond the HIPAA Privacy Rule: Enhancing Privacy, Improving Health Through Research. Washington, DC: National Academies Press , 2009 .

[3] Seungok Lee,et al. Organization of Maximum Surgical Blood Order Schedule (MSBOS) according to the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) , 2008 .

[4] Donald Rubin,et al. Estimating Causal Effects from Large Data Sets Using Propensity Scores , 1997, Annals of Internal Medicine.

[5] Lawrence O. Gostin,et al. Committee on Health Research and the Privacy of Health Information: The HIPAA Privacy Rule , 2009 .

[6] Jeremy A Rassen,et al. Privacy-Maintaining Propensity Score-Based Pooling of Multiple Databases Applied to a Study of Biologics , 2010, Medical care.

[7] J. Avorn,et al. High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data , 2009, Epidemiology.

[8] W. Ray,et al. Evaluating medication effects outside of clinical trials: new-user designs. , 2003, American journal of epidemiology.

[9] L. J. Wei,et al. The Robust Inference for the Cox Proportional Hazards Model , 1989 .